Benzodiazepine derivatives
    128.
    发明授权
    Benzodiazepine derivatives 有权
    苯并二氮杂衍生物

    公开(公告)号:US09550787B2

    公开(公告)日:2017-01-24

    申请号:US14990569

    申请日:2016-01-07

    申请人: ImmunoGen, Inc.

    摘要: The invention relates to novel benzodiazepine derivatives with antiproliferative activity and more specifically to novel benzodiazepines of formula (I) and (II), in which the diazepine ring (B) is fused with a heterocyclic ring (CD), wherein the heterocyclic ring is bicyclic or a compound of formula (III), in which the diazepine ring (B) is fused with a heterocyclic ring (C), wherein the heterocyclic ring is monocyclic. The invention provides cytotoxic dimers of these compounds. The invention also provides conjugates of the monomers and the dimers. The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention. The invention further relates to methods of using the compounds or conjugates for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.

    摘要翻译: 本发明涉及具有抗增殖活性的新型苯并二氮杂衍生物,更具体地涉及式(I)和(II)的新型苯并二氮杂,其中二氮杂环(B)与杂环(CD)稠合,其中杂环是双环的 或其中二氮杂环(B)与杂环(C)稠合的式(III)化合物,其中杂环是单环的。 本发明提供这些化合物的细胞毒二聚体。 本发明还提供了单体和二聚体的共轭物。 本发明还提供了使用本发明的化合物或缀合物来抑制哺乳动物异常细胞生长或治疗增殖性病症的组合物和方法。 本发明还涉及将化合物或缀合物用于体外,原位和体内诊断或治疗哺乳动物细胞或相关病理状况的方法。